A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
Clinical trial NCT03913949 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03913949
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2024-10-20
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.